These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12561439)

  • 21. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
    Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK
    Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of FCM-DNA ploidy pattern, AgNOR counting, hTERT and PCNA expression in differentiating malignant from benign serous effusion].
    Wu LY; Liu BR; Lu J; Ling MD; Chen J; Li P; Jiang Y
    Ai Zheng; 2007 Feb; 26(2):178-82. PubMed ID: 17298749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.
    Lassus H; Staff S; Leminen A; Isola J; Butzow R
    Gynecol Oncol; 2011 Jan; 120(1):11-7. PubMed ID: 20937525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AgNORs count correlates better than grading with the effect of chemotherapy in serous ovarian cancer.
    Gottwald L; Danilewicz M; Suzin J; Wójcik-Krowiranda K; Bieńkiewicz A
    Pol J Pathol; 2003; 54(4):239-42. PubMed ID: 14998291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
    Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
    Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].
    Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sowa M
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleolar organizer regions as a prognostic factor in surgically treated lung cancer patients.
    Lee YC; Chang DB; Lee JM; Luh SP; Kuo SH; Chang YL; Lee CJ
    Thorac Cardiovasc Surg; 1996 Aug; 44(4):204-7. PubMed ID: 8896164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ZNF217 gene was detected in ovarian serous cystadenocarcinoma by fluorescence in situ hybridization].
    Zhong M; Li J; Ding YQ; Song LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):665-7. PubMed ID: 17160949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
    Hu YQ; Liu YJ
    Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma.
    Trerè D; Melchiorri C; Chieco P; Marabini A; Derenzini M
    Gynecol Oncol; 1994 May; 53(2):202-7. PubMed ID: 8188080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma.
    Linder N; Bützow R; Lassus H; Lundin M; Lundin J
    Gynecol Oncol; 2012 Feb; 124(2):311-8. PubMed ID: 22044687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of decreased mitochondrial DNA content with ovarian cancer progression.
    Wang Y; Liu VW; Xue WC; Cheung AN; Ngan HY
    Br J Cancer; 2006 Oct; 95(8):1087-91. PubMed ID: 17047655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of silver-stained nucleolar organizer regions in early diagnosis and prognosis of oral squamous cell carcinoma: a multivariate analysis.
    Pillai KR; Sujathan K; Madhavan J; Abraham EK
    In Vivo; 2005; 19(4):807-12. PubMed ID: 16001464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer.
    Gamzatova Z; Villabona L; Dahlgren L; Dalianis T; Nillson B; Bergfeldt K; Masucci GV
    Gynecol Oncol; 2006 Oct; 103(1):145-50. PubMed ID: 16542716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic and predictive value of syntactic structure analysis in serous carcinoma of the ovary.
    Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Janssen EA; Baak JP; Rollason TP
    Int J Gynecol Pathol; 2008 Apr; 27(2):191-8. PubMed ID: 18317224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.